ResMed (RMD) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $193.01 -2.77%
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $0.69, $0.03 better than the analyst estimate of $0.66. Revenue for the quarter came in at $454.5 million versus the consensus estimate of $446.25 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phoenix Education Partners, Inc. (PXED) Misses Q3 EPS by 14c; Offers Outlook
- ResMed (RMD:AU) (RMD) PT Raised to AUD38.50 at Citi
- Arctic Fox Lithium to rebrand as NiobiumX Mining on CSE
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
